步步高(002251.SZ):累計出售已回購股份850萬股
格隆匯7月1日丨步步高(002251.SZ)公佈,截至2022年6月30日,公司累計通過集中競價方式出售已回購股份(用途為用於維護公司價值及股東權益所必需的股份)數量為850萬股,佔公司總股本(863,903,951股)的比例為0.9839%,成交最高價為8.05元/股,成交最低價為7.86元/股,成交均價為7.94元/股,出售所得資金總額為6742.825萬元(已扣除交易費用),目前公司用途為用於維護公司價值及股東權益所必需的股份的回購股份尚餘407.8488萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.